These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11922953)

  • 1. Pharmacophore modeling of cytochromes P450.
    de Groot MJ; Ekins S
    Adv Drug Deliv Rev; 2002 Mar; 54(3):367-83. PubMed ID: 11922953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B
    Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico methods for predicting ligand binding determinants of cytochromes P450.
    de Groot MJ; Kirton SB; Sutcliffe MJ
    Curr Top Med Chem; 2004; 4(16):1803-24. PubMed ID: 15579109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling of human cytochrome P450-substrate interactions.
    Lewis DF
    Drug Metab Rev; 2002; 34(1-2):55-67. PubMed ID: 11996012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human hepatic cytochromes P450 involved in drug metabolism.
    Wrighton SA; Stevens JC
    Crit Rev Toxicol; 1992; 22(1):1-21. PubMed ID: 1616599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles.
    Lewis DF
    Toxicology; 2000 Apr; 144(1-3):197-203. PubMed ID: 10781888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in cytochrome P450 active site modeling.
    Kemp CA; Maréchal JD; Sutcliffe MJ
    Arch Biochem Biophys; 2005 Jan; 433(2):361-8. PubMed ID: 15581592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human P450s in the metabolism of drugs: molecular modelling of enzyme-substrate interactions.
    Lewis DF
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):5-8. PubMed ID: 16922648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 structure-function: insights from molecular dynamics simulations.
    Nair PC; McKinnon RA; Miners JO
    Drug Metab Rev; 2016 Aug; 48(3):434-52. PubMed ID: 27167388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward Computational Understanding of Molecular Recognition in the Human Metabolizing Cytochrome P450s.
    Kontoyianni M; Lacy B
    Curr Med Chem; 2018; 25(28):3353-3373. PubMed ID: 29484977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B; Chow D; Hu M
    Drug Metab Rev; 2012 May; 44(2):192-208. PubMed ID: 22251142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative modelling of cytochromes P450.
    Kirton SB; Baxter CA; Sutcliffe MJ
    Adv Drug Deliv Rev; 2002 Mar; 54(3):385-406. PubMed ID: 11922954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF; Jacobs MN; Dickins M
    Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Structural Insights into Cytochrome P450 Function.
    Guengerich FP; Waterman MR; Egli M
    Trends Pharmacol Sci; 2016 Aug; 37(8):625-640. PubMed ID: 27267697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity.
    Carosati E
    Drug Discov Today Technol; 2013; 10(1):e167-75. PubMed ID: 24050246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template.
    Lewis DF
    J Inorg Biochem; 2002 Sep; 91(4):502-14. PubMed ID: 12237218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of homology modeling in conjunction with site-directed mutagenesis for analysis of structure-function relationships of mammalian cytochromes P450.
    Szklarz GD; Halpert JR
    Life Sci; 1997; 61(26):2507-20. PubMed ID: 9416773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of recombinant cytochrome p450 enzymes: a drug metabolism perspective.
    Tang W; Wang RW; Lu AY
    Curr Drug Metab; 2005 Oct; 6(5):503-17. PubMed ID: 16248842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.